Key result
NT-proBNP measurement accurately detected left ventricular systolic dysfunction in asymptomatic hypertensive patients.
Why the study?
Does NT-proBNP measurement accurately identify left ventricular systolic dysfunction in asymptomatic patients with a history of hypertension?
Cross-Sectional (n=134)
Does NT-proBNP measurement accurately identify left ventricular systolic dysfunction in asymptomatic patients with a history of hypertension?
NT-proBNP measurement is a highly sensitive screening tool with a strong negative predictive value for ruling out left ventricular systolic dysfunction in asymptomatic hypertensive patients, potentially reducing the need for routine echocardiography.
Answers are grounded in this paper and cite their sources.
May support NT-proBNP screening to reduce echocardiography in asymptomatic hypertension; leaves open prospective validation before practice change.
OBJECTIVE: The role of natriuretic peptides in the screening of left ventricular dysfunction is still unclear. The aim of this study was to assess the usefulness of N-terminal pro-brain natriuretic peptide (NT-proBNP) measurement in asymptomatic patients at high risk of developing left ventricular dysfunction. METHODS: One hundred and thirty-four consecutive ambulatory patients (mean age 56.1 +/- 7 years) were studied and selected on the basis of a history of hypertension of at least 5 years. Systolic dysfunction was defined as an ejection fraction of 45% or less. Statistical analysis was performed by both parametric and nonparametric approaches. Diagnostic accuracy was evaluated by receiver operating characteristic analysis. RESULTS: Echocardiography showed normal left ventricular function in 40 patients, diastolic dysfunction in 80 patients and systolic dysfunction in 14 patients. NT-proBNP levels were significantly higher in patients with systolic dysfunction (356.1 +/- 294.8 vs. 85.2 +/- 85.8 pg/ml; P < 0.05). Receiver operating characteristic analysis showed a high value of the area under the curve (0.89) for the detection of systolic dysfunction with a sensitivity of 83% and a specificity of 80% for a cut-off value of 114 pg/ml and with a negative predictive value of 0.98. CONCLUSION: In asymptomatic patients at high risk for heart failure because of a history of hypertension, the measurement of NT-proBNP levels may represent a useful screening test for left ventricular systolic dysfunction. Therefore, more expensive examinations, such as echocardiography, may be restricted only to patients with higher NT-proBNP levels.
No takes yet. Share an insight, caveat, or question.
Romano et al. (2009) conducted a cross-sectional in Left ventricular dysfunction in asymptomatic hypertensive patients (n=134). NT-proBNP measurement vs. Echocardiography was evaluated on Detection of left ventricular systolic dysfunction (ejection fraction ≤45%) (AUC 0.89, p=<0.05). NT-proBNP measurement accurately detected left ventricular systolic dysfunction in asymptomatic hypertensive patients.
Synapse has enriched 10 related papers. Consider them for comparative context: